Ozanimod as a once-daily oral therapy for Japanese patients with ulcerative colitis: results from the induction period of a Phase 2/3 study (J-True North)

K. Matsuoka,H. Nakase, T. Fujii,T. Hisamatsu, Y. Suzuki, M. Watanabe, Y. Uchikawa, S. Goto, G. Fujimoto, C. Zhang,T. Hibi

JOURNAL OF CROHNS & COLITIS（2024）

Cited 0|Views2

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined